Südhoff T, Wehmeier A, Arning M, Bauser U, Schlömer P, Aul C, Schneider W
Department of Haematology and Oncology, Heinrich-Heine-University, Düsseldorf, Germany.
Leukemia. 1997 Mar;11(3):346-51. doi: 10.1038/sj.leu.2400574.
Aggressive chemotherapy of leukemia increases the risk of severe infections during treatment-induced myelosuppression. However, the assessment of an infectious origin of neutropenic fever is often difficult. Leukocyte adhesion molecules such as E-selectin, intercellular adhesion molecule 1 (ICAM-1) and vascular cell adhesion molecule 1 (VCAM-1) are involved in early inflammatory response. We studied plasma concentrations of their soluble isoforms during 48 treatment courses with myeloablative chemotherapy in 32 leukemic patients. There were 35 febrile episodes during neutropenia. Pneumonia was clinically and microbiologically documented in 15 cases, six had proven infections but normal chest radiograph, and 14 were classified as fever of unknown origin. Longitudinal studies revealed a sustained increase of sICAM-1 plasma levels associated with pneumonia. Increase of sICAM-1 plasma levels distinguished patients with pneumonia from those with fever not related to pneumonia (positive predictive value 0.87, negative predictive value 0.94). Plasma levels of sICAM-1 were elevated in both, fungal and non-fungal pneumonia. Increases of sICAM-1 paralleled first radiographic evidence of pulmonary infiltrations in most cases. In contrast, no elevation of sVCAM-1 or sE-selectin was documented during febrile events prior to recovery of leukocyte counts.
白血病的强化化疗会增加治疗引起的骨髓抑制期间发生严重感染的风险。然而,对中性粒细胞减少性发热的感染源进行评估往往很困难。诸如E-选择素、细胞间黏附分子1(ICAM-1)和血管细胞黏附分子1(VCAM-1)等白细胞黏附分子参与早期炎症反应。我们研究了32例白血病患者在48个疗程的清髓性化疗期间其可溶性异构体的血浆浓度。中性粒细胞减少期间有35次发热发作。15例临床上和微生物学上确诊为肺炎,6例已证实感染但胸部X线片正常,14例归类为不明原因发热。纵向研究显示,sICAM-1血浆水平持续升高与肺炎相关。sICAM-1血浆水平的升高可将肺炎患者与非肺炎相关发热患者区分开来(阳性预测值0.87,阴性预测值0.94)。真菌性和非真菌性肺炎患者的sICAM-1血浆水平均升高。在大多数情况下,sICAM-1的升高与肺部浸润的首次影像学证据平行。相比之下,在白细胞计数恢复之前的发热事件期间,未记录到sVCAM-1或sE-选择素升高。